ACC: Ticagrelor Monotherapy Cuts Bleeding Risk in Acute Coronary Syndrome
Lower risk for clinically relevant bleeding seen in acute coronary syndrome, with no increase in risk for MACCE
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.